ISSN: 2173-5808

Neurología, founded in 1986, is the official scientific Journal of the Spanish Neurology Society (Sociedad Española de Neurología, SEN). It is edited by Dr. Jorge Matías-Guiu and is indexed in the most important international data bases, such as Science Citation Index or Index Medicus/MEDLINE. The Journal accepts works on basic as well applied research on any field of neurology.

See more Open Access Option

Indexed in:

Medline, Directory of Open Access Journals (DOAJ)

Article

Este artículo está disponible en español

Análisis de costes del tratamiento con recambio plasmático terapéutico frente al tratamiento con inmunoglobulinas endovenosas en pacientes con enfermedades neurológicas de base inmune. Propuesta de optimización del uso de hemoderivados plasmáticos

M. Luisa Antelo, S. Zalba Marcos, I. Jericó, M. Sarobe, L. Torné, M. Elena Erro, J.A. García-Erce

10.1016/j.nrl.2023.08.002

Neurologia. 2025;40:344-52

This article is available in English

Cost analysis of treatment with therapeutic plasma exchange versus treatment with intravenous immunoglobulins in patients with immune-based neurological diseases. Proposal for optimising the use of plasmatic blood products

M. Luisa Antelo, S. Zalba Marcos, I. Jericó, M. Sarobe, L. Torné, M. Elena Erro, J.A. García-Erce

10.1016/j.nrleng.2025.04.003

Neurologia. 2025;40:344-52

Publish in

Neurología

Neurología (English Edition) follows the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals

Indexed in:

Follow us:

Article

Análisis de costes del tratamiento con recambio plasmático terapéutico frente al tratamiento con inmunoglobulinas endovenosas en pacientes con enfermedades neurológicas de base inmune. Propuesta de optimización del uso de hemoderivados plasmáticos

Cost analysis of treatment with therapeutic plasma exchange versus treatment with intravenous immunoglobulins in patients with immune-based neurological diseases. Proposal for optimising the use of plasmatic blood products

Subscribe to our newsletter